Cue Biopharma Inc Institutionelles Eigentum
Was ist das Institutionelles Eigentum von Cue Biopharma Inc?
Institutionelles Eigentum von Cue Biopharma Inc ist 50.56%
Was ist die Definition von Institutionelles Eigentum?
Institutionelles Eigentum ist der Betrag der verfügbaren Aktien eines Unternehmens, das sich im Besitz von Investmentfonds oder Pensionskassen, Versicherungsgesellschaften, Wertpapierfirmen, Stiftungen oder anderen großen Körperschaften befindet, die Fonds für Dritte verwalten.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutionelles Eigentum von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Cue Biopharma Inc
Was macht Cue Biopharma Inc?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Unternehmen mit institutionelles eigentum ähnlich Cue Biopharma Inc
- Aptinyx Inc hat Institutionelles Eigentum von 50.50%
- 56728 hat Institutionelles Eigentum von 50.51%
- Calamos Convertible and High Income Fund hat Institutionelles Eigentum von 50.51%
- Aritzia hat Institutionelles Eigentum von 50.52%
- Eos Enterprises hat Institutionelles Eigentum von 50.52%
- Shurgard Self Storage S.A hat Institutionelles Eigentum von 50.54%
- Cue Biopharma Inc hat Institutionelles Eigentum von 50.56%
- Danimer Scientific hat Institutionelles Eigentum von 50.57%
- NB Global Floating Rate Income Fund hat Institutionelles Eigentum von 50.58%
- ASOS Plc hat Institutionelles Eigentum von 50.58%
- HeadHunter PLC hat Institutionelles Eigentum von 50.60%
- Midas Gold hat Institutionelles Eigentum von 50.61%
- Midas Gold hat Institutionelles Eigentum von 50.61%